MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-TN-02-0049087
Athenese-Dx Private Limited - healthcare in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹73.45 Cr
▲ 1% YoY
Net profit · FY 2024
₹4.26 Cr
Net margin 5.8%
EBITDA · FY 2024
₹6.74 Cr
EBITDA margin 9.2%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹70.16 Lakh
Issued & subscribed
Satisfied charges
₹50 Lakh
No open charges
Company age
14 yrs
Est. 2012
Employees · EPFO
289
Provident fund records
About Athenese-Dx Private Limited
Data last updated:
Athenese-Dx Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 24 February 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U85100TN2012PTC084632. Its GSTIN is 07AAKCA4573B1ZU (Delhi).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹70.16 Lakh. It is led by directors including Arunkumar Chakravarthy (Whole-Time Director) and Catherine Yaping Chen.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Module No.407 & 408 4th Floor Ticel Bio Park II No.5 Csir Road Taramani, Chennai, Tamil Nadu, India – 600113.
As per the financials filed for FY 2024, the company reported a revenue of ₹73.45 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹4.26 Cr (net margin 5.8%) and EBITDA of ₹6.74 Cr (EBITDA margin 9.2%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 15% over five years.
The company has about 289 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Athenese-Dx. As per MCA filings, the company has satisfied charges of ₹50 Lakh on record. Court records list 29 cases involving the company, including 24 filed by the company and 5 filed against it; 4 cases are pending. The company has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹4.06 Cr; the latest was in September 2023. The company has 14 MSME Form 1 returns on record between 2019 and 2024, listing 847 overdue payments to 74 micro and small suppliers.
Athenese-Dx Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0049087). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website athenesedx.com.
Company details
CIN U85100TN2012PTC084632
Registration Number 084632
Incorporation Date 24 February 2012
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TN-02-0049087
Key People
Arunkumar Chakravarthy Whole-Time Director Catherine Yaping Chen Director Srikrishnan Additional Director Recognitions & Rankings of Athenese-Dx
Contact details
Athenese-Dx Private Limited's registered office is in Chennai, Tamil Nadu. Its website is athenesedx.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressModule No.407 & 408 4th Floor Ticel Bio Park II No.5 Csir Road Taramani, Chennai, Tamil Nadu, India – 600113
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Athenese-Dx Private Limited, buy the company report.
Comprehensive company report
Athenese-Dx Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Athenese-Dx operates one associated brand: Athenese-Dx. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops, manufactures, and markets in vitro diagnostic tests and instruments for healthcare. | athenesedx.com |
Business activity
The main business activities of Athenese-Dx are trade, manufacturing and support service to organizations. In detail, this covers wholesale trading, other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities and other support services to organizations. 3 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | |
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities | |
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Athenese-Dx Private Limited, buy the company report.
Financials of Athenese-Dx Private Limited
FY 2025 filings availableAthenese-Dx Private Limited reported revenue of ₹73.45 Cr (up 1% YoY) for FY 2024.
Revenue · FY 2024
₹73.45 Cr ▲ 1%
Net profit · FY 2024
₹4.26 Cr margin 5.8%
EBITDA · FY 2024
₹6.74 Cr margin 9.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 12%
5 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▼ 1%
3 years · compounded
▲ 3%
5 years · compounded
▲ 15%
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 1% growth in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.74 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.26 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.2% | ||||
| Net Profit Margin | 5.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Athenese-Dx Private Limited, buy the company report.
Board of directors of Athenese-Dx Private Limited
Athenese-Dx has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arunkumar Chakravarthy | Whole-Time Director | 06 Jan 2017 | 9 Years 9 Months | Current |
| Catherine Yaping Chen | Director | 30 Dec 2020 | 5 Years 9 Months | Current |
| Srikrishnan | Additional Director | 14 Nov 2025 | 0 Years 11 Months | Current |
Auditor
Athenese-Dx Private Limited is audited by S.M.MANI BHURAT for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.M.MANI BHURAT | FY 2023 | 228297 |
Shareholding
The shareholding of Athenese-Dx Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Athenese-Dx Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹50 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 May 2020 | 100338474 | Sidbi | ₹50 Lakh | Satisfied |
To see the full charge records of Athenese-Dx Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Athenese-Dx Private Limited has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹4.06 Cr; the latest was in September 2023.
Total deals
6
Secondary share transfers
4
Funding rounds
2
Disclosed funding
₹4.06 Cr
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2023 | Funding round | ₹1.31 Cr | Investors: Athenese Inc |
| Jul 2021 | Funding round | ₹2.75 Cr | Investors: Athenese Inc |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Feb 2014 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Athenese-Dx Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Athenese-Dx Private Limited has 29 court cases on record: 24 filed by Athenese-Dx, 5 filed against it. 4 cases are pending and 25 are disposed.
Total cases
29
Filed by the company
24
Filed against the company
5
Pending
4
Disposed
25
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 22 | 1 | 4 |
| High courts | 7 | 4 | 0 |
Cases on record (5 of 29)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chennai, Tamil Nadu | Appeal | Filed against the company by Otabu Certification Pvt Ltd | Disposed |
| High Court, TAMIL NADU | Court case (CRL MP) | Filed against the company by M/S.Otabu Certification Pvt Ltd and 2 others | Disposed |
| High Court, TAMIL NADU | Court case (CRL OP) | Filed against the company by M/S.Otabu Certification Pvt Ltd and 2 others | Disposed |
| High Court, TAMIL NADU | Court case (C.S(COMM DIV)) | Filed by the company against Medonica Healthcare Private Limited and Another and 1 other | Disposed |
| High Court, TAMIL NADU | Original application | Filed by the company against Medonica Healthcare Private Limited and Another and 1 other | Disposed |
To see the full case history of Athenese-Dx Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Athenese-Dx Private Limited has 14 MSME Form 1 returns on record between 2019 and 2024, listing 847 overdue payments to 74 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 74)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Sai Sakthi Printers | |||
| Desiccants India LLP | |||
| an individual supplier | |||
| Sanguine Logistics Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Athenese-Dx Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Athenese-Dx Private Limited has a workforce of 289 employees on its EPFO records as of May 11, 2024, across 1 active EPFO establishment.
Employee count
289
Active EPFO establishments
1
Employee growth
-0.34%
GST
Athenese-Dx has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAKCA4573B1ZU | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Athenese-Dx Private Limited, buy the company report.
Recent activity
Athenese-Dx Private Limited has 11 board changes on record since 2014: 4 appointments and 7 cessations. The latest: Srikrishnan was appointed as Additional Director on 14 Nov 2025.
Appointed
Srikrishnan was appointed as Additional Director.
AGM
Athenese-Dx Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Athenese-Dx Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge registered on 28 May 2020 via Charge ID 100338474 with Sidbi was fully satisfied on 04 May 2022.
Appointed
Catherine Yaping Chen was appointed as Director.
Ceased
Selvaraju Govindasamy ceased to be Additional Director.
Ceased
Bala Pandi ceased to be Director.
Appointed
Selvaraju Govindasamy was appointed as Director.
Charges
A charge with Sidbi amounted to Rs. 0.50 Cr with Charge ID 100338474 was registered on 28 May 2020.
Ceased
Tamilmani Elavarasan ceased to be Additional Director.
Ceased
Catherine Yaping Chen ceased to be Director.
Ceased
Arunkumar Chakravarthy ceased to be Additional Director.
4 earlier events are in the company report.
Frequently asked questions
Athenese-Dx is an active private limited company based in Chennai, Tamil Nadu, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 24 February 2012 (14+ years old) and is registered under CIN U85100TN2012PTC084632.
Athenese-Dx has 3 current directors:
- Arunkumar Chakravarthy - Whole-Time Director
- Catherine Yaping Chen - Director
- Srikrishnan - Additional Director
The latest financial statements of Athenese-Dx on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Athenese-Dx is 07AAKCA4573B1ZU, registered in Delhi.
The CIN (Corporate Identification Number) of Athenese-Dx is U85100TN2012PTC084632. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Athenese-Dx has 29 court cases on record: 24 filed by the company and 5 filed against it. 4 are pending. Most are in the district courts.
Athenese-Dx was incorporated on 24 February 2012, making it 14+ years old. It is registered with the Registrar of Companies, Chennai.
Athenese-Dx has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹4.06 Cr; the latest was in September 2023.
Srikrishnan was appointed as Additional Director on 14 Nov 2025. Catherine Yaping Chen was appointed as Director on 30 Dec 2020. Selvaraju Govindasamy ceased to be Additional Director on 30 Dec 2020. Athenese-Dx has 11 board changes on record in total.
Yes, Athenese-Dx is registered as a medium enterprise under Udyam registration (number: UDYAM-TN-02-0049087).
Athenese-Dx has 14 MSME Form 1 returns on record between 2019 and 2024, listing 847 overdue payments to 74 micro and small suppliers. The latest return was filed on 23 Apr 2024.